Home » Topics » Science » New compound

New compound
RSS

LY-23728, 5-HT2B antagonist reported by Lilly

Aug. 16, 1996

Histamine H3 agonist increases slow-wave sleep in rats

Aug. 16, 1996

GW-5823: CCK-A agonist for treatment of obesity

Aug. 16, 1996

Antiarthritic MMP inhibitor described by Chugai

Aug. 16, 1996

HIV integrase inhibitor effective, non-toxic in vitro

Aug. 16, 1996

Preclinical results presented for RCK-11

Aug. 16, 1996

RO-11 demonstrates efficacy in phase III as DVT prevention agent

Aug. 9, 1996

KRH-594: Wakunaga's angiotensin II antagonist

Aug. 9, 1996

Palauolol: A novel antiinflammatory phospholipase A2 inhibitor

Aug. 9, 1996

RD4-2025: Selective HIV-1 reverse transcriptase inhibitor in vitro

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...